BRPI0908024A2 - uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer - Google Patents

uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer

Info

Publication number: BRPI0908024A2
Authority: BR; Brazil
Prior art keywords: adenosylmethionine; sod; sam; medicaments; alzheimer
Prior art date: 2008-02-29

Application number

BRPI0908024A

Other languages

English (en)

Inventor

Fuso Andrea

Rossini Mauro

Damiani Rosellina

Scarpa Sigfrido

Original Assignee

Gnosis Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-29

Filing date

2009-02-25

Publication date

2018-11-06

2009-02-25 Application filed by Gnosis Spa filed Critical Gnosis Spa

2018-11-06 Publication of BRPI0908024A2 publication Critical patent/BRPI0908024A2/pt

Links

208000024827 Alzheimer disease Diseases 0.000 title 1
MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 title 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 title 1
229960001570 ademetionine Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI0908024A 2008-02-29 2009-02-25 uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer BRPI0908024A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08425123A EP2095828A1 (en)	2008-02-29	2008-02-29	Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease
PCT/EP2009/001323 WO2009106302A1 (en)	2008-02-29	2009-02-25	Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease

Publications (1)

Publication Number	Publication Date
BRPI0908024A2 true BRPI0908024A2 (pt)	2018-11-06

Family

ID=39529658

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0908024A BRPI0908024A2 (pt)	2008-02-29	2009-02-25	uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer

Country Status (25)

Country	Link
US (1)	US8778337B2 (pt)
EP (2)	EP2095828A1 (pt)
JP (1)	JP5362747B2 (pt)
KR (1)	KR101297763B1 (pt)
CN (2)	CN104189895B (pt)
AU (1)	AU2009218723B2 (pt)
BR (1)	BRPI0908024A2 (pt)
CA (1)	CA2716893C (pt)
CY (1)	CY1116782T1 (pt)
DK (1)	DK2249868T3 (pt)
ES (1)	ES2550461T3 (pt)
GE (1)	GEP20125638B (pt)
HR (1)	HRP20151241T1 (pt)
HU (1)	HUE028183T2 (pt)
IL (1)	IL207807A (pt)
MX (1)	MX2010009384A (pt)
NZ (1)	NZ587608A (pt)
PL (1)	PL2249868T3 (pt)
PT (1)	PT2249868E (pt)
RS (1)	RS54442B1 (pt)
RU (1)	RU2472513C2 (pt)
SI (1)	SI2249868T1 (pt)
UA (1)	UA97440C2 (pt)
WO (1)	WO2009106302A1 (pt)
ZA (1)	ZA201006085B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20150064423A (ko) *	2013-12-03	2015-06-11	경상대학교산학협력단	오스모틴을 유효성분으로 함유하는 인지기능 개선용 조성물
KR101689681B1 (ko) *	2016-06-07	2016-12-26	경상대학교산학협력단	오스모틴을 유효성분으로 함유하는 인지기능 개선용 조성물
US20250064879A1 (en)	2021-09-30	2025-02-27	Korea Institute Of Oriental Medicine	Composition for treating alzheimer's disease including mixed extract of pinellia tuber, zizyphi fructus, glycyrrhiza radix, ginseng radix, zingiberis rhizoma, scutellariae radix, and coptidis rhizoma as active ingredient

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5519058A (en) *	1989-03-17	1996-05-21	Cedars-Sinai Medical Center	Method for treatment with dimercaptosuccinic acid (DMSA) of hypertension, diabetic neuphropathy and atherosclerosis
CN1099224A (zh) *	1993-08-23	1995-03-01	庭野七郎	人参叶加工的食品及其制造方法
US6096778A (en) *	1997-10-07	2000-08-01	Cephalon, Inc.	α-ketoamide multicatalytic protease inhibitors
US6797289B2 (en) *	1998-02-13	2004-09-28	Nutramax Laboratories, Inc.	Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20020025926A1 (en) *	2000-08-30	2002-02-28	Hebert Rolland F.	Enantiomers of S-adenosyl-l-methionine
IT1317920B1 (it)	2000-10-20	2003-07-15	Univ Roma	S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US6759395B2 (en) *	2000-12-18	2004-07-06	Orchid Chemicals & Pharmaceuticals, Ltd.	Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
FR2822381B1 (fr) *	2001-03-20	2004-10-22	Bio Obtention Sc	Extrait de cucumis melo enrobe et/ou microencapsule dans un agent liposoluble a base de matiere grasse
ITMI20012462A1 (it) *	2001-11-22	2003-05-22	Gnosis Srl	Processo per la preparazione di compresse comprendenti s-adenosilmetionina
WO2004034963A2 (en) *	2002-05-17	2004-04-29	Eisai Co., Ltd.	Methods and compositions using cholinesterase inhibitors
EP1667699B1 (en) *	2003-10-03	2010-08-18	Green Meadows Research. LLC.	Compositions comprising lotus extracts and methyl donors
DK1731596T5 (da)	2005-06-09	2013-09-23	Gnosis Spa	Tørrede, frysetørrede og/eller mikroindkapslede celler af Saccharomyces cerevisiae med et højt indhold af (S)-(+)-S-adenosyl-L-methionin

2008
- 2008-02-29 EP EP08425123A patent/EP2095828A1/en not_active Withdrawn
2009
- 2009-02-25 US US12/919,515 patent/US8778337B2/en active Active
- 2009-02-25 PL PL09714406T patent/PL2249868T3/pl unknown
- 2009-02-25 MX MX2010009384A patent/MX2010009384A/es active IP Right Grant
- 2009-02-25 NZ NZ587608A patent/NZ587608A/xx not_active IP Right Cessation
- 2009-02-25 RS RS20150717A patent/RS54442B1/sr unknown
- 2009-02-25 SI SI200931313T patent/SI2249868T1/sl unknown
- 2009-02-25 RU RU2010135467/15A patent/RU2472513C2/ru active
- 2009-02-25 KR KR1020107018940A patent/KR101297763B1/ko not_active Expired - Fee Related
- 2009-02-25 CN CN201410384204.XA patent/CN104189895B/zh active Active
- 2009-02-25 EP EP09714406.7A patent/EP2249868B1/en active Active
- 2009-02-25 AU AU2009218723A patent/AU2009218723B2/en active Active
- 2009-02-25 ES ES09714406.7T patent/ES2550461T3/es active Active
- 2009-02-25 PT PT97144067T patent/PT2249868E/pt unknown
- 2009-02-25 UA UAA201010400A patent/UA97440C2/ru unknown
- 2009-02-25 DK DK09714406.7T patent/DK2249868T3/en active
- 2009-02-25 CN CN2009801064845A patent/CN101965197A/zh active Pending
- 2009-02-25 HR HRP20151241TT patent/HRP20151241T1/hr unknown
- 2009-02-25 BR BRPI0908024A patent/BRPI0908024A2/pt not_active Application Discontinuation
- 2009-02-25 HU HUE09714406A patent/HUE028183T2/en unknown
- 2009-02-25 WO PCT/EP2009/001323 patent/WO2009106302A1/en not_active Ceased
- 2009-02-25 GE GEAP200911930A patent/GEP20125638B/en unknown
- 2009-02-25 JP JP2010548015A patent/JP5362747B2/ja not_active Expired - Fee Related
- 2009-02-25 CA CA2716893A patent/CA2716893C/en active Active
2010
- 2010-08-26 IL IL207807A patent/IL207807A/en active IP Right Grant
- 2010-08-26 ZA ZA2010/06085A patent/ZA201006085B/en unknown
2015
- 2015-10-12 CY CY20151100917T patent/CY1116782T1/el unknown

Also Published As

Publication number	Publication date
PL2249868T3 (pl)	2016-03-31
KR20100126326A (ko)	2010-12-01
CA2716893A1 (en)	2009-09-03
RS54442B1 (sr)	2016-06-30
HUE028183T2 (en)	2016-12-28
RU2010135467A (ru)	2012-04-10
NZ587608A (en)	2012-07-27
PT2249868E (pt)	2015-11-03
SI2249868T1 (sl)	2015-12-31
GEP20125638B (en)	2012-09-10
CN101965197A (zh)	2011-02-02
EP2249868A1 (en)	2010-11-17
WO2009106302A1 (en)	2009-09-03
CN104189895B (zh)	2016-08-31
HRP20151241T1 (hr)	2015-12-18
MX2010009384A (es)	2010-12-21
KR101297763B1 (ko)	2013-08-20
CA2716893C (en)	2014-05-20
ZA201006085B (en)	2011-10-26
CN104189895A (zh)	2014-12-10
US8778337B2 (en)	2014-07-15
AU2009218723A1 (en)	2009-09-03
AU2009218723B2 (en)	2014-01-30
ES2550461T3 (es)	2015-11-10
IL207807A (en)	2015-08-31
EP2249868B1 (en)	2015-09-02
DK2249868T3 (en)	2015-11-23
RU2472513C2 (ru)	2013-01-20
UA97440C2 (en)	2012-02-10
US20110020301A1 (en)	2011-01-27
JP2011513257A (ja)	2011-04-28
EP2095828A1 (en)	2009-09-02
JP5362747B2 (ja)	2013-12-11
CY1116782T1 (el)	2017-03-15
IL207807A0 (en)	2010-12-30

Similar Documents

Publication	Publication Date	Title
BRPI0818799A2 (pt)	2015-04-22	Composições para o tratamento da doença de parkinson
CL2007003635A1 (es)	2008-08-22	Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer.
BRPI0911874A2 (pt)	2018-05-22	composições combinadas para o tratamento da doença de alzheimer e doenças relacionadas com zonisamida e acamprosato
CY2017013I2 (el)	2017-07-12	ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
BRPI1011876A2 (pt)	2015-09-22	"composição farmacêutica estável e métodos de uso da mesma"
HUS1700033I1 (hu)	2017-09-28	Illékony alkilezõszerek stabilizált készítményei és eljárások azok alkalmazására
HUE037082T2 (hu)	2018-08-28	Új lipidek és készítmények terápiás hatóanyagok szállítására
BRPI0906576A2 (pt)	2015-07-07	Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer
IL193678A (en)	2016-04-21	Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
BRPI1014854A2 (pt)	2016-05-03	"conjugados polímero-agente, partículas, composições, e métodos de uso relacionados"
BRPI0810081A2 (pt)	2014-10-21	Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
CL2007001427A1 (es)	2008-05-16	Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
IL212568A (en)	2016-10-31	Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals
IL204741A (en)	2015-11-30	Ceramide History for the Treatment of Multiple Cyst Diseases and Pharmaceuticals Containing These History
BRPI0912292A2 (pt)	2015-10-20	composições e métodos para o uso de células no tratamento do tecido cardíaco.
BRPI0819501A2 (pt)	2015-05-26	"dispositivo para fototerapia, método cosmético para bronzeamento, uso do dispositivo, kit, uso de curcumia, curcuminoides, pró-drogas ou metabólitos dos mesmos e composição farmacêutica"
BRPI1009781A2 (pt)	2016-03-08	compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos
BR112013014189A2 (pt)	2017-08-01	composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI0720689A2 (pt)	2014-02-25	Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer
BRPI0607198A2 (pt)	2016-11-01	composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
BRPI0910737A2 (pt)	2019-09-24	composto, pró-droga, agente farmacêutico, método para profilaxia ou tratamento de doenças do trato urinário inferior em um mamífero, e, uso de um composto ou uma pró-droga do mesmo.
PT1781298E (pt)	2012-02-03	Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias
CL2008000318A1 (es)	2008-08-08	Compuestos derivados de n-(2,3,4,4a,5,6-hexahidro-1h-pirazino(1,2-a)quinolina-8-carbonil)bencenosulfonamida; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar el cancer de vejiga, cerebro, m
PT2056804E (pt)	2014-07-11	Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
BRPI0910570A2 (pt)	2015-09-22	uso de bioconjugados, e, formulações farmacêuticas

Legal Events

Date	Code	Title	Description
2018-11-21	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2019-01-22	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-04-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-05-05	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-12-01	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-03-23	B09B	Patent application refused [chapter 9.2 patent gazette]
2021-06-08	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL